[Ip-health] Ketamine to be discussed at WHO/Expert Committee on Drug Dependence

BAGOZZI, Daniela bagozzid at who.int
Mon Nov 9 04:21:09 PST 2015

The WHO Expert Committee on Drug Dependence will discuss updated evidence on the essential medicine ketamine at its 37th meeting, from 16-20 November<UrlBlockedError.aspx>, in Geneva. The update is in response to a request for more information about ketamine from the UN Commission on Narcotic Drugs.

Ketamine is a widely used anaesthetic and analgesic in low- and middle-income countries, as well as in conflict zones and acute emergencies. At a meeting earlier this year, the UN Commission on Narcotic Drugs considered placing the substance under international control but postponed making a decision on the matter. In its reviews of ketamine at recent meetings, the Expert Committee on Drug Dependence has acknowledged concerns about abuse but found that it does not appear to pose a global public health risk significant enough to warrant scheduling.

The Expert Committee's opening session is open to the public. It will feature commentary on ketamine from interested parties.

Opening session of the WHO Expert Committee on Drug Dependence
Time:                     9-11am<UrlBlockedError.aspx>
Date:                     Monday 16 November<-CSCO-3h--UrlBlockedError.aspx>
Location:              Salle C,  WHO Headquarters, Avenue Appia 20, Geneva<-CSCO-3h--UrlBlockedError.aspx>
Contact:               ecddsecretariat at who.int<mailto:ecddsecretariat at who.int>

More information: http://www.who.int/medicines/access/controlled-substances/ecdd/

Daniela Bagozzi
Information and communication
WHO/Essential Medicines and Health Products
E-mail: bagozzid at who.int<mailto:bagozzid at who.int>
Tel. +41 22 791 19 90
Cell. +41 79 60 37 281

More information about the Ip-health mailing list